“…The significance of placenta-derived CLP-induced endothelial dysfunction has several implications for studies on the pathophysiology of PE. First, placenta-derived CLP induces endothelial inflammatory responses (demonstrated by upregulation of endothelial selectins), 16 supporting the idea that CLP/chymase is an inflammatory protease; Second, placenta-derived CLP was able to mobilize angiotensin II, a powerful systemic vasoconstrictor, generation by endothelial cells, because CLP/ chymase is a potent non-ACE angiotensin II generating enzyme 23,24 ; lastly, our present study shows that CLPderived from preeclamptic placenta disrupts endothelial junction protein integrity leading to increased endothelial permeability. All of these findings show that in PE, ECs are an important target for CLP, and increased CLP activity leads to the pathophysiology of preeclampsia, that is, exaggerated inflammatory response, augmented vasoconstriction, and increased vascular permeability.…”